University of Kansas Medical Center-IM-Pulmonary and Critical Care Medicine ( Site 0102)

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD	Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, chronic obstructive pulmonary disease, hypertensive disorder, lung disorder, obstructive lung disease, pulmonary hypertension, respiratory system disorder, vascular disorder	Active, not recruiting	Phase 2	2026-05-01		NCT05612035

Clinical trials